Curat Global’s Biogen BIIB Stock Holding History

Curat Global’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Hold	503	–	–	0.09%	137
2026 Q1	$92.2K	Hold	503	–	–	0.09%	138
2025 Q4	$88.5K	Hold	503	–	–	0.1%	140
2025 Q3	$70.5K	Hold	503	–	–	0.07%	161
2025 Q2	$63.2K	Hold	503	–	–	0.06%	165
2025 Q1	$68.8K	Buy	+503	New	+$71.9K	0.08%	165

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Curat Global's BIIB Position: Q2 2026 in Review

Curat Global held its Biogen (BIIB) position steady in Q2 2026 at 503 shares worth $107K. The position accounts for 0.09% of the portfolio, ranked #137.

Curat Global first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Curat Global held 503 shares of Biogen worth $107K as of Q2 2026.
Curat Global left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.09% of Curat Global's portfolio in Q2 2026, its #137 holding.
Curat Global first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.